Gelteq Ltd

Gelteq Ltd.

Drug Manufacturers - Specialty & Generic Healthcare Clayton, VIC, United States GELS (NCM)

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Drug Manufacturers - Specialty & Generic Companies

View All →

Frequently Asked Questions

Has Gelteq Ltd had layoffs?
No layoff events have been recorded for Gelteq Ltd in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Gelteq Ltd have?
Gelteq Ltd has approximately 7 employees.
What industry is Gelteq Ltd in?
Gelteq Ltd operates in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector.
Is Gelteq Ltd a publicly traded company?
Yes, Gelteq Ltd is publicly traded under the ticker symbol GELS on the NCM. The company has a market capitalization of approximately $0.01 billion.
Where is Gelteq Ltd headquartered?
Gelteq Ltd is headquartered in Clayton, VIC, United States at Monash Innovation Labs, Clayton, VIC 3800, Australia.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.